Aetna Surescripts Integration for Pharmacy Benefit Prior Authorization

Navigating the complexities of pharmacy benefit prior authorizations for Aetna members requires robust electronic solutions. Klivira streamlines the Aetna Surescripts integration, ensuring efficient processing of retail and specialty drug ePA requests.

For revenue cycle directors and prior authorization coordinators, manual pharmacy PA processes with Aetna can be a significant bottleneck. Understanding the specific channels and requirements for Aetna's pharmacy benefit, administered through CVS Caremark and enabled by Surescripts ePA, is crucial for improving operational efficiency and reducing delays in patient care.

Understanding Aetna's Pharmacy Benefit PA Ecosystem

Aetna's pharmacy benefit prior authorizations are administered through CVS Caremark, Aetna's PBM. For outpatient retail pharmacy PA, including many specialty drugs, submission channels route through established ePA partners such as Surescripts. This distinct pathway requires precise data exchange and adherence to specific clinical criteria.

Surescripts' Role in Aetna Specialty Drug ePA

The Surescripts ePA platform is a critical component for electronic prior authorization of pharmacy-benefit specialty medications dispensed at retail pharmacies for Aetna members. While some specialty injectables and infusions may fall under the medical benefit, Surescripts specifically facilitates the ePA process for pharmacy-benefit specialty drugs, ensuring eligibility verification and submission through a standardized electronic channel.

Key Data Elements for Aetna Surescripts Submissions

Patient demographics and insurance information.
Prescribing provider details and NPI.
Specific drug (NDC), dosage, and therapeutic indication.
Relevant Aetna Clinical Policy Bulletin (CPB) number and supporting clinical documentation.
Prior medication history, including documented step therapy adherence where applicable.

Aetna's Policy Framework for Pharmacy PAs

Aetna's medical necessity criteria for pharmacy benefits, including specialty drugs, are detailed in their Clinical Policy Bulletins (CPBs). These CPBs are publicly available and provide the canonical identifier for all policy citations. Effective prior authorization via Surescripts requires accurate cross-referencing of the prescribed medication with the applicable CPB to ensure all clinical requirements are met.

Turnaround Time Considerations and Regulatory Impact

Prior authorization turnaround times for Aetna pharmacy benefits are influenced by state-mandated minimums and NCQA Utilization Management accreditation standards. For Aetna's Medicare Advantage, Medicaid managed-care, CHIP, and QHP-on-FFM lines of business, CMS-0057-F mandates 72-hour decisions for standard PA requests and 24-hour for expedited, with phased compliance through 2027 for electronic PA API conformance. Commercial lines are not directly impacted by CMS-0057-F.

Klivira's Automation for Aetna Surescripts Integration

Klivira integrates directly with EMRs and connects to the Surescripts ePA network, automating the data extraction, submission, and status tracking for Aetna pharmacy benefit prior authorizations. This automation minimizes manual data entry, reduces submission errors, and accelerates decision times, freeing PA coordinators to focus on complex cases.

Frequently asked questions

What is the role of CVS Caremark in Aetna Surescripts ePA?

CVS Caremark acts as Aetna's Pharmacy Benefit Manager (PBM). They administer the pharmacy benefit, and prior authorization requests submitted through Surescripts for retail pharmacy claims are processed via CVS Caremark's systems.

Does Surescripts handle all Aetna specialty drug PAs?

Surescripts facilitates ePA for specialty drugs that fall under the *pharmacy benefit* and are dispensed at retail pharmacies. Specialty injectables or infused medications managed under the *medical benefit* follow a different prior authorization workflow, typically not through Surescripts.

How do Aetna's Clinical Policy Bulletins (CPBs) apply to Surescripts ePA?

Aetna's CPBs define the medical necessity criteria for both medical and pharmacy benefits. For Surescripts ePA submissions, providers must ensure that the clinical documentation aligns with the requirements outlined in the relevant Aetna CPB for the prescribed medication.

What are the typical turnaround times for Aetna pharmacy PAs submitted via Surescripts?

Turnaround times vary by line of business and state regulations. For impacted lines (Medicare Advantage, Medicaid, etc.), CMS-0057-F mandates 72 hours for standard and 24 hours for expedited requests. For commercial plans, state-specific requirements and NCQA standards (e.g., 15 calendar days for non-urgent) apply.

Is Aetna's Surescripts integration impacted by CMS-0057-F?

Yes, for Aetna's Medicare Advantage, Medicaid managed-care, CHIP, and QHP-on-FFM lines of business, CMS-0057-F impacts electronic prior authorization requirements, including API conformance by 2027. This rule does not directly apply to Aetna's commercial lines of business.